United States

Gilead Pharmasset LLC (VRUS)

Track

Ticker: VRUS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
121.95
Quantity 24,242 -1.4%
Value US$2,106,908
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
233.37
Quantity 10,417 +23.1%
Value US$1,306,121
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
488.69
Quantity 79,177 +17.4%
Value US$2,210,063
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
74.56
Quantity 3,124 -100.0%
Value US$232,925
Price P Schaefer President & CEO Executive Director
Transaction date
Sale
Price
79.33
Quantity 40,000 -5.0%
Value US$3,173,316
Price P Schaefer President and CEO Executive Director
Transaction date
Sale
Price
65.63
Quantity 40,000 -5.0%
Value US$2,625,032
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
65.63
Quantity 3,124 -100.0%
Value US$205,015
Price P Schaefer President and CEO Executive Director
Transaction date
Sale
Price
120.15
Quantity 20,000 -5.0%
Value US$2,403,006
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
119.99
Quantity 8,929 -55.4%
Value US$1,071,391
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
119.99
Quantity 937 -100.0%
Value US$112,431
Price P Schaefer President and CEO Executive Director
Transaction date
Sale
Price
110.47
Quantity 20,000 -5.0%
Value US$2,209,326
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
111.83
Quantity 938 -100.0%
Value US$104,897
Price P Schaefer President and CEO Executive Director
Transaction date
Sale
Price
100.54
Quantity 20,000 -5.0%
Value US$2,010,706
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
109.08
Quantity 10,000 -100.0%
Value US$1,090,800
Williamson Robert F III Non-Executive Director
Transaction date
Sale
Price
104.36
Quantity 31,666 -91.3%
Value US$3,304,607
LEUTZINGER KURT Chief Financial Officer Officer
Transaction date
Sale
Price
102.88
Quantity 11,287 -5.7%
Value US$1,161,207
LEUTZINGER KURT Chief Financial Officer Officer
Transaction date
Sale
Price
102.61
Quantity 9,546 -4.6%
Value US$979,515
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
99.04
Quantity 40,000 -83.3%
Value US$3,961,584
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
99.85
Quantity 9,500 -56.9%
Value US$948,575
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
99.00
Quantity 20,000 -100.0%
Value US$1,980,068
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
100.60
Quantity 9,375 -100.0%
Value US$943,125
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
100.60
Quantity 8,437 -100.0%
Value US$848,762
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
100.60
Quantity 21,875 -100.0%
Value US$2,200,625
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
100.60
Quantity 10,416 -100.0%
Value US$1,047,850
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
64.00
Quantity 6,279 -27.3%
Value US$401,856
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
29.50
Quantity 5,000 -23.1%
Value US$147,500
OTTO MICHAEL J. Chief Scientific Officer Officer
Transaction date
Sale
Price
29.50
Quantity 12,811 -37.1%
Value US$377,924
Berrey M Michelle Chief Medical Officer Officer
Transaction date
Sale
Price
32.53
Quantity 2,976 -100.0%
Value US$96,807
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
20.88
Quantity 400,000 -12.5%
Value US$8,352,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
20.88
Quantity 400,000 -11.1%
Value US$8,352,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
22.41
Quantity 10,000 -0.3%
Value US$224,100
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
22.95
Quantity 100,000 -2.7%
Value US$2,295,000
OTTO MICHAEL Exec.VP,Pharm.Research Officer
Transaction date
Sale
Price
21.97
Quantity 4,600 -19.1%
Value US$101,062
OTTO MICHAEL Exec.VP,Pharm.Research Officer
Transaction date
Sale
Price
21.95
Quantity 4,500 -65.1%
Value US$98,775
OTTO MICHAEL Exec.VP,Pharm.Research Officer
Transaction date
Sale
Price
21.94
Quantity 8,200 -22.3%
Value US$179,908
OTTO MICHAEL Exec.VP,Pharm.Research Officer
Transaction date
Sale
Price
21.92
Quantity 9,300 -20.2%
Value US$203,856
OTTO MICHAEL Exec.VP,Pharm.Research Officer
Transaction date
Sale
Price
21.90
Quantity 13,400 -22.5%
Value US$293,460
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.11
Quantity 200 +4.7%
Value US$2,022
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.10
Quantity 192 +4.7%
Value US$1,939
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.09
Quantity 300 +7.9%
Value US$3,027
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.07
Quantity 58 +1.5%
Value US$584
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.11
Quantity 500 +15.4%
Value US$5,053
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.68
Quantity 119 +3.8%
Value US$1,271
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.67
Quantity 100 +3.3%
Value US$1,067
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.64
Quantity 200 +7.1%
Value US$2,128
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.65
Quantity 300 +11.9%
Value US$3,195
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.63
Quantity 300 +13.4%
Value US$3,189
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.60
Quantity 131 +6.2%
Value US$1,389
INOUYE MICHAEL K Non-Executive Director
Transaction date
Purchase
Price
10.59
Quantity 100 +5.0%
Value US$1,058
LUBETKIN PAUL Executive VP & General Counsel Officer
Transaction date
Purchase
Price
10.14
Quantity 125 +33.3%
Value US$1,268
LUBETKIN PAUL Executive VP & General Counsel Officer
Transaction date
Purchase
Price
10.65
Quantity 175 +87.5%
Value US$1,864
LUBETKIN PAUL Executive VP & General Counsel Officer
Transaction date
Purchase
Price
10.64
Quantity 200 +inf%
Value US$2,128
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.75
Quantity 600 -100.0%
Value US$11,250
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.72
Quantity 1 -0.2%
Value US$19
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.71
Quantity 300 -33.3%
Value US$5,613
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.70
Quantity 300 -25.0%
Value US$5,610
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.69
Quantity 499 -29.4%
Value US$9,326
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.65
Quantity 701 -29.2%
Value US$13,074
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.63
Quantity 100 -4.0%
Value US$1,863
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.59
Quantity 100 -3.3%
Value US$1,859
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.58
Quantity 200 -6.2%
Value US$3,716
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.55
Quantity 99 -3.0%
Value US$1,836
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.50
Quantity 600 -15.4%
Value US$11,100
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.43
Quantity 300 -7.1%
Value US$5,529
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.40
Quantity 300 -6.7%
Value US$5,520
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.39
Quantity 70 -1.5%
Value US$1,287
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.38
Quantity 100 -2.1%
Value US$1,838
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.37
Quantity 100 -2.1%
Value US$1,837
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.35
Quantity 1,430 -23.1%
Value US$26,240
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.32
Quantity 400 -6.1%
Value US$7,328
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.29
Quantity 300 -4.3%
Value US$5,487
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.27
Quantity 400 -5.5%
Value US$7,308
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.26
Quantity 400 -5.2%
Value US$7,304
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.25
Quantity 1,672 -17.8%
Value US$30,514
Rogers Michael D. Chief Development Officer Officer
Transaction date
Sale
Price
18.24
Quantity 600 -6.0%
Value US$10,944
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-12-05 2011-12-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
24,242 -1.4%
121.95
US$2,106,908 		24,242 -1.4% 121.95 US$2,106,908
2011-12-05 2011-12-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
10,417 +23.1%
233.37
US$1,306,121 		10,417 +23.1% 233.37 US$1,306,121
2011-11-07 2011-11-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
79,177 +17.4%
488.69
US$2,210,063 		79,177 +17.4% 488.69 US$2,210,063
2011-11-03 2011-11-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
3,124 -100.0%
74.56
US$232,925 		3,124 -100.0% 74.56 US$232,925
2011-10-05 2011-10-03 S Sale Price P Schaefer

President & CEO

Executive Director
40,000 -5.0%
79.33
US$3,173,316 		40,000 -5.0% 79.33 US$3,173,316
2011-09-06 2011-09-01 S Sale Price P Schaefer

President and CEO

Executive Director
40,000 -5.0%
65.63
US$2,625,032 		40,000 -5.0% 65.63 US$2,625,032
2011-09-06 2011-09-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
3,124 -100.0%
65.63
US$205,015 		3,124 -100.0% 65.63 US$205,015
2011-08-03 2011-08-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
120.15
US$2,403,006 		20,000 -5.0% 120.15 US$2,403,006
2011-08-03 2011-08-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
8,929 -55.4%
119.99
US$1,071,391 		8,929 -55.4% 119.99 US$1,071,391
2011-08-03 2011-08-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
937 -100.0%
119.99
US$112,431 		937 -100.0% 119.99 US$112,431
2011-07-05 2011-07-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
110.47
US$2,209,326 		20,000 -5.0% 110.47 US$2,209,326
2011-07-05 2011-07-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
938 -100.0%
111.83
US$104,897 		938 -100.0% 111.83 US$104,897
2011-06-03 2011-06-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
100.54
US$2,010,706 		20,000 -5.0% 100.54 US$2,010,706
2011-05-11 2011-05-09 S Sale Rogers Michael D.

Chief Development Officer

Officer
10,000 -100.0%
109.08
US$1,090,800 		10,000 -100.0% 109.08 US$1,090,800
2011-05-10 2011-05-06 S Sale Williamson Robert F III Non-Executive Director
31,666 -91.3%
104.36
US$3,304,607 		31,666 -91.3% 104.36 US$3,304,607
2011-05-10 2011-05-06 S Sale LEUTZINGER KURT

Chief Financial Officer

Officer
11,287 -5.7%
102.88
US$1,161,207 		11,287 -5.7% 102.88 US$1,161,207
2011-05-09 2011-05-05 S Sale LEUTZINGER KURT

Chief Financial Officer

Officer
9,546 -4.6%
102.61
US$979,515 		9,546 -4.6% 102.61 US$979,515
2011-05-05 2011-05-03 S Sale CONRAD HERBERT J Non-Executive Director
40,000 -83.3%
99.04
US$3,961,584 		40,000 -83.3% 99.04 US$3,961,584
2011-04-29 2011-04-28 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
9,500 -56.9%
99.85
US$948,575 		9,500 -56.9% 99.85 US$948,575
2011-04-29 2011-04-27 S Sale Rogers Michael D.

Chief Development Officer

Officer
20,000 -100.0%
99.00
US$1,980,068 		20,000 -100.0% 99.00 US$1,980,068
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
9,375 -100.0%
100.60
US$943,125 		9,375 -100.0% 100.60 US$943,125
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
8,437 -100.0%
100.60
US$848,762 		8,437 -100.0% 100.60 US$848,762
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
21,875 -100.0%
100.60
US$2,200,625 		21,875 -100.0% 100.60 US$2,200,625
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
10,416 -100.0%
100.60
US$1,047,850 		10,416 -100.0% 100.60 US$1,047,850
2011-03-24 2011-03-22 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
6,279 -27.3%
64.00
US$401,856 		6,279 -27.3% 64.00 US$401,856
2010-10-01 2010-10-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
5,000 -23.1%
29.50
US$147,500 		5,000 -23.1% 29.50 US$147,500
2010-09-29 2010-09-28 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
12,811 -37.1%
29.50
US$377,924 		12,811 -37.1% 29.50 US$377,924
2010-06-18 2010-06-17 S Sale Berrey M Michelle

Chief Medical Officer

Officer
2,976 -100.0%
32.53
US$96,807 		2,976 -100.0% 32.53 US$96,807
2009-09-24 2009-09-24 S Sale QVT Associates GP LLC Large shareholder
400,000 -12.5%
20.88
US$8,352,000 		400,000 -12.5% 20.88 US$8,352,000
2009-09-24 2009-09-24 S Sale QVT Associates GP LLC Large shareholder
400,000 -11.1%
20.88
US$8,352,000 		400,000 -11.1% 20.88 US$8,352,000
2009-09-24 2009-09-23 S Sale QVT Associates GP LLC Large shareholder
10,000 -0.3%
22.41
US$224,100 		10,000 -0.3% 22.41 US$224,100
2009-09-24 2009-09-22 S Sale QVT Associates GP LLC Large shareholder
100,000 -2.7%
22.95
US$2,295,000 		100,000 -2.7% 22.95 US$2,295,000
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
4,600 -19.1%
21.97
US$101,062 		4,600 -19.1% 21.97 US$101,062
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
4,500 -65.1%
21.95
US$98,775 		4,500 -65.1% 21.95 US$98,775
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
8,200 -22.3%
21.94
US$179,908 		8,200 -22.3% 21.94 US$179,908
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
9,300 -20.2%
21.92
US$203,856 		9,300 -20.2% 21.92 US$203,856
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
13,400 -22.5%
21.90
US$293,460 		13,400 -22.5% 21.90 US$293,460
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
200 +4.7%
10.11
US$2,022 		200 +4.7% 10.11 US$2,022
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
192 +4.7%
10.10
US$1,939 		192 +4.7% 10.10 US$1,939
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +7.9%
10.09
US$3,027 		300 +7.9% 10.09 US$3,027
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
58 +1.5%
10.07
US$584 		58 +1.5% 10.07 US$584
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
500 +15.4%
10.11
US$5,053 		500 +15.4% 10.11 US$5,053
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
119 +3.8%
10.68
US$1,271 		119 +3.8% 10.68 US$1,271
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
100 +3.3%
10.67
US$1,067 		100 +3.3% 10.67 US$1,067
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
200 +7.1%
10.64
US$2,128 		200 +7.1% 10.64 US$2,128
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +11.9%
10.65
US$3,195 		300 +11.9% 10.65 US$3,195
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +13.4%
10.63
US$3,189 		300 +13.4% 10.63 US$3,189
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
131 +6.2%
10.60
US$1,389 		131 +6.2% 10.60 US$1,389
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
100 +5.0%
10.59
US$1,058 		100 +5.0% 10.59 US$1,058
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
125 +33.3%
10.14
US$1,268 		125 +33.3% 10.14 US$1,268
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
175 +87.5%
10.65
US$1,864 		175 +87.5% 10.65 US$1,864
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
200 +inf%
10.64
US$2,128 		200 +inf% 10.64 US$2,128
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -100.0%
18.75
US$11,250 		600 -100.0% 18.75 US$11,250
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1 -0.2%
18.72
US$19 		1 -0.2% 18.72 US$19
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -33.3%
18.71
US$5,613 		300 -33.3% 18.71 US$5,613
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -25.0%
18.70
US$5,610 		300 -25.0% 18.70 US$5,610
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
499 -29.4%
18.69
US$9,326 		499 -29.4% 18.69 US$9,326
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
701 -29.2%
18.65
US$13,074 		701 -29.2% 18.65 US$13,074
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -4.0%
18.63
US$1,863 		100 -4.0% 18.63 US$1,863
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -3.3%
18.59
US$1,859 		100 -3.3% 18.59 US$1,859
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
200 -6.2%
18.58
US$3,716 		200 -6.2% 18.58 US$3,716
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
99 -3.0%
18.55
US$1,836 		99 -3.0% 18.55 US$1,836
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -15.4%
18.50
US$11,100 		600 -15.4% 18.50 US$11,100
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -7.1%
18.43
US$5,529 		300 -7.1% 18.43 US$5,529
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -6.7%
18.40
US$5,520 		300 -6.7% 18.40 US$5,520
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
70 -1.5%
18.39
US$1,287 		70 -1.5% 18.39 US$1,287
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -2.1%
18.38
US$1,838 		100 -2.1% 18.38 US$1,838
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -2.1%
18.37
US$1,837 		100 -2.1% 18.37 US$1,837
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1,430 -23.1%
18.35
US$26,240 		1,430 -23.1% 18.35 US$26,240
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -6.1%
18.32
US$7,328 		400 -6.1% 18.32 US$7,328
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -4.3%
18.29
US$5,487 		300 -4.3% 18.29 US$5,487
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -5.5%
18.27
US$7,308 		400 -5.5% 18.27 US$7,308
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -5.2%
18.26
US$7,304 		400 -5.2% 18.26 US$7,304
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1,672 -17.8%
18.25
US$30,514 		1,672 -17.8% 18.25 US$30,514
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -6.0%
18.24
US$10,944 		600 -6.0% 18.24 US$10,944
Explore more

More insider trading research around Gilead Pharmasset LLC

More insider trades in United States
Insider trading in North America